BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35521441)

  • 1.
    Ren G; Chen P; Tang J; Guo W; Wang R; Li N; Li Y; Zhang G; Wang R; Zhang S
    RSC Adv; 2020 Apr; 10(29):17270-17279. PubMed ID: 35521441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice.
    Jin Q; Zhou X; Niu X; Ping C; Dong X; Duan D; Wang R; Chen Y; Pan F; Yang F; Yang X; Zhang G; Wang R; Zhang S; Ren G
    Colloids Surf B Biointerfaces; 2024 May; 241():113992. PubMed ID: 38833960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled nanoparticles with antitumor activity.
    Ren G; Duan D; Wang G; Wang R; Li Y; Zuo H; Zhang Q; Zhang G; Zhao Y; Wang R; Zhang S
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112614. PubMed ID: 35700564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and cellular uptake evaluation of redox-responsive docetaxel prodrug self-assembled nanoparticles.
    Ren G; Chen P; Tang J; Wang R; Duan S; Wang R; Xie Y; Zhang S
    Drug Dev Ind Pharm; 2018 Apr; 44(4):598-607. PubMed ID: 29157014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine pharmacokinetics and antimalarial pharmacodynamics of dihydroartemisinin trimer self-assembled nanoparticles.
    Guo W; Li N; Ren G; Wang R; Chai L; Li Y; Wang X; Yang Q; Wang R; Zhang G; Yang L; Yi B; Zhang S
    Parasitol Res; 2021 Aug; 120(8):2827-2837. PubMed ID: 34272998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel prodrug and hematoporphyrin co-assembled nanoparticles for anti-tumor combination of chemotherapy and photodynamic therapy.
    Ren G; Li Y; Ping C; Duan D; Li N; Tang J; Wang R; Guo W; Niu X; Ji Q; Zhang G; Wang R; Zhang S
    Drug Deliv; 2022 Dec; 29(1):3358-3369. PubMed ID: 36397301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer.
    Phung CD; Le TG; Nguyen VH; Vu TT; Nguyen HQ; Kim JO; Yong CS; Nguyen CN
    Pharm Res; 2020 Jun; 37(7):129. PubMed ID: 32548664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.
    Liu K; Dai L; Li C; Liu J; Wang L; Lei J
    Sci Rep; 2016 Jul; 6():29461. PubMed ID: 27377918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
    Lages EB; Fernandes RS; Andrade MMS; Paiyabhroma N; de Oliveira RB; Fernandes C; Cassali GD; Sicard P; Richard S; Branco de Barros AL; Ferreira LAM
    Biomed Pharmacother; 2021 Dec; 144():112373. PubMed ID: 34794238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intelligent triggering of nanomicelles based on a ROS-activated anticancer prodrug and photodynamic therapy (PDT)-synergistic therapy for lung cancers.
    Chen L; Xu R; Ding Y; Wang C; Zhang S; Sun Z; Chen Y; Mi Y; Gao M; Ma X; Li L
    Eur J Med Chem; 2022 Nov; 241():114622. PubMed ID: 35952401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Assembled Nanoparticles Platform Based on Pectin-Dihydroartemisinin Conjugates for Codelivery of Anticancer Drugs.
    Liu Y; Zheng D; Ma Y; Dai J; Li C; Xiao S; Liu K; Liu J; Wang L; Lei J; He J
    ACS Biomater Sci Eng; 2018 May; 4(5):1641-1650. PubMed ID: 33445320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and anti-tumor activities of disulfide-linked docetaxel-dihydroartemisinin nanoconjugates.
    Li N; Guo W; Li Y; Zuo H; Zhang H; Wang Z; Zhao Y; Yang F; Ren G; Zhang S
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111018. PubMed ID: 32304917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ginsenoside Rg_3 based liposomes target delivery of dihydroartemisinin and paclitaxel for treatment of triple-negative breast cancer].
    Liu H; Liu Y; Li N; Zhang GQ; Wang M
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3472-3484. PubMed ID: 37474984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform.
    Liang Z; Li J; Zhu B
    Drug Des Devel Ther; 2020; 14():4519-4531. PubMed ID: 33149550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione-sensitive PEGylated curcumin prodrug nanomicelles: Preparation, characterization, cellular uptake and bioavailability evaluation.
    Zhang HY; Sun CY; Adu-Frimpong M; Yu JN; Xu XM
    Int J Pharm; 2019 Jan; 555():270-279. PubMed ID: 30471374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of magnetic dihydroartemisinin nano-liposome in inhibiting the proliferation of head and neck squamous cell carcinomas.
    Li H; Li X; Shi X; Li Z; Sun Y
    Phytomedicine; 2019 Mar; 56():215-228. PubMed ID: 30668343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study.
    Wu C; Zhang Y; Yang D; Zhang J; Ma J; Cheng D; Chen J; Deng L
    Int J Nanomedicine; 2019; 14():75-85. PubMed ID: 30587986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity.
    Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G
    Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.